Efficient method for production of high yields of Fab fragments in Drosophila S2 cells.

Archive ouverte

Backovic, Marija | Johansson, Daniel X. | Klupp, Barbara G. | Mettenleiter, Thomas C. | Persson, Mats A. A. | Rey, Félix A.

Edité par CCSD ; Oxford University Press (OUP) -

International audience. Fab molecules are used as therapeutic agents, and are invaluable tools in structural biology. We report here a method for production of recombinant Fab in Drosophila S2 cells for use in structural biology. Stably transfected S2 cell lines expressing the Fab were created within weeks. The recombinant Fab was secreted, and after affinity and size exclusion chromatography, 16 mg of pure protein were obtained from a liter of cell culture. The Fab was functional and formed a complex with its cognate antigen as demonstrated by co-precipitation and size exclusion chromatography. Biochemical characterization indicated that the Fab from S2 cells is less extensively glycosylated than the Fab obtained by digestion of antibody produced in hybridoma cells, a feature that may be advantageous for the purposes of crystallogenesis. Taken together, obtaining recombinant Fab from the S2 cells has been a faster and considerably more cost-effective method compared with the enzymatic digestion of the monoclonal antibody.

Consulter en ligne

Suggestions

Du même auteur

Structure-function dissection of the Pseudorabies virus glycoprotein B fusion loops

Archive ouverte | Vallbracht, Melina | CCSD

International audience. Conserved across the Herpesviridae family, glycoprotein B (gB) is responsible for driving fusion of the viral envelope with the host cell membrane for entry upon receptor binding and activati...

The disulfide bonds in glycoprotein e2 of hepatitis C virus reveal the tertiary organization of the molecule.

Archive ouverte | Krey, Thomas | CCSD

International audience. Hepatitis C virus (HCV), a major cause of chronic liver disease in humans, is the focus of intense research efforts worldwide. Yet structural data on the viral envelope glycoproteins E1 and E...

The Therapeutic Antibody LM609 Selectively Inhibits Ligand Binding to Human α V β 3 Integrin via Steric Hindrance

Archive ouverte | Borst, Andrew | CCSD

International audience. The LM609 antibody specifically recognizes αVβ3 integrin and inhibits angiogenesis, bone resorption, and viral infections in an arginine-glycine-aspartate-independent manner. LM609 entered ph...

Chargement des enrichissements...